Skip to content
Screener

AngioDynamics ANGO Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

TFX
TeleflexTFX
$34.05M+35.8%
Abbott logo
AbbottABT
Stryker logo
StrykerSYK
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT
IAR
Integra LifeSciencesIART

Other financials

Income statement

See full
Revenue$86.6M+8.0%
Gross profit$46.8M+10.8%
Operating income-$10.2M-76.1%
Net income-$11.4M-88.5%
EPS (diluted)-$0.27-80.0%

Balance sheet

See full
Cash & equivalents$53.9M-3.6%
Total debt$11.0M+8.0%
Total equity$170.8M-6.6%
Total assets$267.2M-4.6%

Cash flow

See full
Operating cash flow$17.5M
CapEx$413.0K-46.8%
Free cash flow$17.0M

Valuation

See full
Market cap$650.99M+89.6%
Enterprise value$608.08M+104%
P/S+0.9×

Profitability

See full
Gross margin54.6%+0.7pp
Operating margin-12.5%-1.0pp
Net margin-11.5%-0.1pp
FCF margin0.2%

Returns & leverage

See full
Return on equity-20.8%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The source filing: AngioDynamics’s 10-K, filed July 14, 2026.

Filed
Jul 14, 2026, 3:42 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-048138
Line itemYear ended May 31, 2026Year ended May 31, 2025Year ended May 31, 2024
Research and development29,44726,22231,512
Sales and marketing113,401103,135102,818
General and administrative43,69142,09241,164
Amortization of intangibles10,68210,31813,048
Goodwill impairment159,476
Change in fair value of contingent consideration272432
Acquisition, restructuring and other items, net17,59815,62053,182
Total operating expenses214,819197,659401,632

Item 15. Exhibits, Financial Statement Schedules.

FAQ

What is AngioDynamics's amortization of capitalized software and acquired intangible assets?
AngioDynamics (ANGO) reported amortization of capitalized software and acquired intangible assets of $2.72M in Q1 2026.
How has AngioDynamics's amortization of capitalized software and acquired intangible assets changed year-over-year?
AngioDynamics's amortization of capitalized software and acquired intangible assets increased by 5.0% year-over-year, from $2.59M to $2.72M.
What is the long-term trend for AngioDynamics's amortization of capitalized software and acquired intangible assets?
Over 4 years (2022 to 2026), AngioDynamics's amortization of capitalized software and acquired intangible assets has grown at a -13.9% compound annual growth rate (CAGR), from $19.46M to $10.68M.

Ask your AI about AngioDynamics's amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude